ORCHARD THERAPEUTICS PLC Financing Cash Flow
ORCHARD THERAPEUTICS PLC reported Financing Cash Flow of $60.09 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was -$2.35M.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was $30.93M.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was $31.51M.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was -$811.00K, a 640.67% decline year-over-year.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) financing activities for fiscal 2022 was -$693.00K, a 100.44% decline from fiscal 2021.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) financing activities for fiscal 2021 was $158.07M, a 3915.90% increase from fiscal 2020.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) financing activities for fiscal 2020 was $3.94M, a 97.50% decline from fiscal 2019.
- ORCHARD THERAPEUTICS PLC net cash provided by (used in) financing activities for fiscal 2019 was $157.45M, a 55.63% decline from fiscal 2018.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $28.58M derived: sum of 2 quarters · filed 2023-11-13 | $60.09M 10-Q · filed 2023-11-13 | $59.28M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $30.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $62.44M 10-Q · filed 2023-08-10 | $61.63M derived: sum of 3 quarters · filed 2023-08-10 | $61.61M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $31.51M 10-Q · filed 2023-05-15 | $30.70M derived: sum of 2 quarters · filed 2023-05-15 | $30.68M derived: sum of 3 quarters · filed 2023-11-13 | |
| 2022-12-31 | -$811.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$830.00K derived: sum of 2 quarters · filed 2023-11-13 | -$693.00K 10-K · filed 2023-03-14 | |
| 2022-09-30 | -$19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $118.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $137.00K 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $4.21M derived: sum of 2 quarters · filed 2023-03-14 | $11.63M derived: sum of 3 quarters · filed 2023-03-14 | $158.07M 10-K · filed 2023-03-14 |
| 2021-09-30 | $4.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $11.48M derived: sum of 2 quarters · filed 2022-11-14 | $157.92M 10-Q · filed 2022-11-14 | $159.02M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $7.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $153.86M 10-Q · filed 2022-08-04 | $154.96M derived: sum of 3 quarters · filed 2022-08-04 | $155.21M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $146.43M 10-Q · filed 2022-05-12 | $147.54M derived: sum of 2 quarters · filed 2022-05-12 | $147.79M derived: sum of 3 quarters · filed 2022-05-12 | $148.93M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.35M derived: sum of 2 quarters · filed 2022-03-30 | $2.50M derived: sum of 3 quarters · filed 2022-03-30 | $3.94M 10-K · filed 2022-03-30 |
| 2020-09-30 | $249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.39M derived: sum of 2 quarters · filed 2021-11-04 | $2.83M 10-Q · filed 2021-11-04 | $4.42M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $2.58M 10-Q · filed 2021-08-04 | $4.17M derived: sum of 3 quarters · filed 2021-08-04 | $3.91M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $1.44M 10-Q · filed 2021-05-13 | $3.02M derived: sum of 2 quarters · filed 2021-05-13 | $2.76M derived: sum of 3 quarters · filed 2021-05-13 | $158.89M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $1.32M derived: sum of 2 quarters · filed 2021-03-02 | $157.45M derived: sum of 3 quarters · filed 2021-03-02 | $157.45M 10-K · filed 2021-03-02 |
| 2019-09-30 | -$262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $155.86M derived: sum of 2 quarters · filed 2020-11-03 | $155.87M 10-Q · filed 2020-11-03 | $361.34M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | $156.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $156.13M 10-Q · filed 2020-08-06 | $361.60M derived: sum of 3 quarters · filed 2020-08-06 | $508.72M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $5.00K 10-Q · filed 2020-05-07 | $205.47M derived: sum of 2 quarters · filed 2020-05-07 | $352.59M derived: sum of 3 quarters · filed 2020-05-07 | $352.62M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $205.47M derived: 10-K 12 month − 6-K 9 month · filed 2020-02-27 | $352.59M derived: sum of 2 quarters · filed 2020-02-27 | $352.61M derived: sum of 3 quarters · filed 2020-02-27 | $354.86M 10-K · filed 2020-02-27 |
| 2018-09-30 | $147.12M derived: 6-K 9 month − 6-K 6 month · filed 2019-11-07 | $147.14M derived: sum of 2 quarters · filed 2019-11-07 | $149.39M 6-K · filed 2019-11-07 | |
| 2018-06-30 | $25.00K derived: 6-K 6 month − 6-K 3 month · filed 2019-08-08 | $2.27M 6-K · filed 2019-08-08 | ||
| 2018-03-31 | $2.25M 6-K · filed 2019-05-28 | |||
| 2017-12-31 | $115.70M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $18.03M 20-F · filed 2019-03-22 |